Company / Return on Equity (ROE)
Progyny Return on Equity (ROE) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
11.3%
FY2025
5-year range
8.1% / 26.1%
FY2021-FY2025
Trend
-11.9%
vs FY2024
Sector context
#45 of 147
Health Care
What the data says
At 11.3%, Progyny's return on equity (roe) ranks #45 of 147 in the Health Care sector. Return on Equity (ROE) has fluctuated over the past 7 years, ranging from -7.5% in FY2019 to 27.8% in FY2020.
Based on SEC 10-K filings.
11.3% in FY2025 with a 5-year CAGR of -16.5%.
Remained stable around 11.3% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +3.3pp
- 5-Year Change
- -16.5pp
- 10-Year Change
- -
Sector benchmark
#45 of 147 in Health CareTop 31% of 147This company 11.3% Sector average -3.1%
▼
+463.4% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 11.9% year-over-year.
- Currently 14.5pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2020.
- Lowest return on equity (roe) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 11.3% | -11.9% |
| FY2024 | 12.9% | +14.8% |
| FY2023 | 11.2% | +39.3% |
| FY2022 | 8.1% | -69.2% |
| FY2021 | 26.1% | -6.1% |
| FY2020 | 27.8% | +471.1% |
| FY2019 | -7.5% | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026